Coronary Stents: A Global Strategic Business Report
San Jose, CA (Vocus) October 27, 2010
Global stents market, in particular the Drug Eluting Stents (DES) segment is back on the growth trajectory, after witnessing a considerable decline in recent years. The DES market was hard hit in recent years following reports questioning the performance and efficiency of the technology, along with increasing concerns related to late stent thrombosis risk. However, recent studies demonstrating the safety and efficacy of DES is encouraging a comeback of the technology. In 2008, new clinical data assisted in the alleviation of concerns associated with thrombosis. This resulted in the development of new devices and a stable expansion in stent sales. With coronary stent vendors striding ahead with high-profile innovations, product advancements are likely to inundate the stent market over the next few years as stated by the new market research report on Coronary Stents. The market is opening up doors for smaller market players engaged in the development of bioabsorbable coronary stents. These stents are comparatively less invasive, and immediately dissolve in the body, thus reducing the risks of clotting. In addition, developments are underway for products incorporating other improved technologies such as platinum coated stainless steel stents, diamond carbon coating, and gene therapy/antibody coated stents.
The United States represents the largest market for coronary stents. Europe and Japan comprise the other major markets. Drug Eluting Stents continue to snap up a sizeable share of the global coronary stents market by aggressively denting the market dominance of bare metal stents. With the market demand scaling to new heights in the forthcoming years, the DES market is set to register sturdy double-digit growths. Newer drug eluting formulations along with improvements in cardiac care are set to revolutionize the outcomes of coronary stenting in coming years. Among the emerging markets, Asia-Pacific is evolving as a potential market for several foreign players.
Worldwide coronary stent market is highly concentrated, and shows predominance of Johnson & Johnson and Boston Scientific, vying for the top slot. Key players profiled in the study include Abbott Vascular, Biosensors International, Boston Scientific, Cordis Corporation, Cook Group, Medtronic, and OrbusNeich.
The research report titled “Coronary Stents: A Global Strategic Business Report” announced by Global Industry Analysts, Inc., provides a comprehensive review of market trends, drivers, competition, research and development, regulatory approvals, recent developments, mergers, acquisitions, and other strategic industry activities. Analysis is presented for major geographic markets such as United States, Japan, France, Germany, the UK, Italy, Spain, Asia, and rest of world. Analytics are provided in terms of product segments including Bare Metal Stents and Drug Eluting Stents.
For more details about this comprehensive market research report, please visit –http://www.strategyr.com/Coronary_Stents_Market_Report.asp
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world’s largest market research publishers. The company employs over 800 people worldwide and publishes more than 1200 full-scale research reports each year. Additionally, the company also offers thousands of smaller research products including company reports, market trend reports, and industry reports encompassing all major industries worldwide.
Global Industry Analysts, Inc.
Web Site http://www.StrategyR.com/
# # #